These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30829039)

  • 1. AIE Featured Inorganic-Organic Core@Shell Nanoparticles for High-Efficiency siRNA Delivery and Real-Time Monitoring.
    He X; Yin F; Wang D; Xiong LH; Kwok RTK; Gao PF; Zhao Z; Lam JWY; Yong KT; Li Z; Tang BZ
    Nano Lett; 2019 Apr; 19(4):2272-2279. PubMed ID: 30829039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid-based nanoparticles in the systemic delivery of siRNA.
    Lin Q; Chen J; Zhang Z; Zheng G
    Nanomedicine (Lond); 2014 Jan; 9(1):105-20. PubMed ID: 24354813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic delivery of siRNA by T7 peptide modified core-shell nanoparticles for targeted therapy of breast cancer.
    Yu MZ; Pang WH; Yang T; Wang JC; Wei L; Qiu C; Wu YF; Liu WZ; Wei W; Guo XY; Zhang Q
    Eur J Pharm Sci; 2016 Sep; 92():39-48. PubMed ID: 27355138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimuli-responsive hybrid nanocarriers developed by controllable integration of hyperbranched PEI with mesoporous silica nanoparticles for sustained intracellular siRNA delivery.
    Prabhakar N; Zhang J; Desai D; Casals E; Gulin-Sarfraz T; Näreoja T; Westermarck J; Rosenholm JM
    Int J Nanomedicine; 2016; 11():6591-6608. PubMed ID: 27994460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifunctional selenium nanoparticles: Chiral selectivity of delivering MDR-siRNA for reversal of multidrug resistance and real-time biofluorescence imaging.
    Chen Q; Yu Q; Liu Y; Bhavsar D; Yang L; Ren X; Sun D; Zheng W; Liu J; Chen LM
    Nanomedicine; 2015 Oct; 11(7):1773-84. PubMed ID: 25959925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of siRNA payloads to target KRAS-mutant cancer.
    Yuan TL; Fellmann C; Lee CS; Ritchie CD; Thapar V; Lee LC; Hsu DJ; Grace D; Carver JO; Zuber J; Luo J; McCormick F; Lowe SW
    Cancer Discov; 2014 Oct; 4(10):1182-1197. PubMed ID: 25100204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanocarrier Mediated siRNA Delivery Targeting Stem Cell Differentiation.
    Fernandes F; Kotharkar P; Chakravorty A; Kowshik M; Talukdar I
    Curr Stem Cell Res Ther; 2020; 15(2):155-172. PubMed ID: 31789134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
    Li TS; Yawata T; Honke K
    Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-delivery of hypoxia inducible factor-1α small interfering RNA and 5-fluorouracil to overcome drug resistance in gastric cancer SGC-7901 cells.
    Chen Y; Sun L; Guo D; Wu Z; Chen W
    J Gene Med; 2017 Dec; 19(12):. PubMed ID: 29106062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticle-siRNA: A potential cancer therapy?
    Young SW; Stenzel M; Yang JL
    Crit Rev Oncol Hematol; 2016 Feb; 98():159-69. PubMed ID: 26597018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasound-mediated nanobubble destruction (UMND) facilitates the delivery of A10-3.2 aptamer targeted and siRNA-loaded cationic nanobubbles for therapy of prostate cancer.
    Wu M; Zhao H; Guo L; Wang Y; Song J; Zhao X; Li C; Hao L; Wang D; Tang J
    Drug Deliv; 2018 Nov; 25(1):226-240. PubMed ID: 29313393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo delivery of small interfering RNA to tumors and their vasculature by novel dendritic nanocarriers.
    Ofek P; Fischer W; Calderón M; Haag R; Satchi-Fainaro R
    FASEB J; 2010 Sep; 24(9):3122-34. PubMed ID: 20385622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of hybrid-type modified chitosan derivative nanoparticles for the intracellular delivery of midkine-siRNA in hepatocellular carcinoma cells.
    Zhong J; Huang HL; Li J; Qian FC; Li LQ; Niu PP; Dai LC
    Hepatobiliary Pancreat Dis Int; 2015 Feb; 14(1):82-9. PubMed ID: 25655295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monodispersed brush-like conjugated polyelectrolyte nanoparticles with efficient and visualized siRNA delivery for gene silencing.
    Jiang R; Lu X; Yang M; Deng W; Fan Q; Huang W
    Biomacromolecules; 2013 Oct; 14(10):3643-52. PubMed ID: 24040909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cationic liquid crystalline nanoparticles for the delivery of synthetic RNAi-based therapeutics.
    Gentile E; Oba T; Lin J; Shao R; Meng F; Cao X; Lin HY; Mourad M; Pataer A; Baladandayuthapani V; Cai D; Roth JA; Ji L
    Oncotarget; 2017 Jul; 8(29):48222-48239. PubMed ID: 28637023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic delivery of siRNA by aminated poly(α)glutamate for the treatment of solid tumors.
    Polyak D; Krivitsky A; Scomparin A; Eliyahu S; Kalinski H; Avkin-Nachum S; Satchi-Fainaro R
    J Control Release; 2017 Jul; 257():132-143. PubMed ID: 27356019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid-Based Liquid Crystalline Nanoparticles Facilitate Cytosolic Delivery of siRNA via Structural Transformation.
    He S; Fan W; Wu N; Zhu J; Miao Y; Miao X; Li F; Zhang X; Gan Y
    Nano Lett; 2018 Apr; 18(4):2411-2419. PubMed ID: 29561622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic delivery of siRNA with cationic lipid assisted PEG-PLA nanoparticles for cancer therapy.
    Yang XZ; Dou S; Sun TM; Mao CQ; Wang HX; Wang J
    J Control Release; 2011 Dec; 156(2):203-11. PubMed ID: 21839126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted Delivery with Imaging Assessment of siRNA Expressing Nanocassettes into Cancer.
    Chen W; Yang L
    Methods Mol Biol; 2016; 1372():49-59. PubMed ID: 26530914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quick synthesis of a novel combinatorial delivery system of siRNA and doxorubicin for a synergistic anticancer effect.
    Chen M; Wang L; Wang F; Li F; Xia W; Gu H; Chen Y
    Int J Nanomedicine; 2019; 14():3557-3569. PubMed ID: 31190812
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.